Target- |
MechanismIonising radiation emitters |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. |
First Approval Date18 Jun 2015 |
100 Clinical Results associated with BILLEV PHARMA ApS
0 Patents (Medical) associated with BILLEV PHARMA ApS
100 Deals associated with BILLEV PHARMA ApS
100 Translational Medicine associated with BILLEV PHARMA ApS